22nd Century explores growing cannabis in tobacco plants

Developing tobacco plants into a source of cannabis for medical purposes is the goal of a biotechnology company with operations in Mocksville.

22nd Century Group Inc. said Thursday it has opened molecular biology laboratories on the Buffalo Niagara Medical campus that are focused in research involving industrial hemp/cannabis and tobacco.

Based in Clarence, N.Y., 22nd Century opened cigarette manufacturing operations in Mocksville in 2014 through acquiring the production equipment of defunct Renegade Tobacco Inc. It has 39 employees overall.

The company’s main focus is producing very-low-nicotine traditional cigarettes. It has applied to the Food and Drug Administration for approval to sell and market the cigarettes as a reduced-risk tobacco option.

The cannabis research is tied to a worldwide license agreement with Anandia Laboratories Inc. of Vancouver, Canada, that provides 22nd Century with exclusive U.S. rights to genes required for cannabinoid

...
e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.